Similar articles

• Disseminated candidiasis due to amphotericin B-resistant Candida albicans.

  Conly J, Rennie R, Johnson J, Farah S, Hellman L. Conly J, et al. J Infect Dis. 1992 Apr;165(4):761-4. doi: 10.1093/infdis/165.4.761. J Infect Dis. 1992. PMID: 1285732
• Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.

  Paniagua GL, Monroy E, Negrete E, Vaca S. Paniagua GL, et al. Rev Latinoam Microbiol. 2002 Apr-Jun;44(2):65-8. Rev Latinoam Microbiol. 2002. PMID: 17063773
• Sensitivity of Candida albicans from patients with chronic oral candidiasis.

  Holbrook WP, Kippax R. Holbrook WP, et al. Postgrad Med J. 1979 Sep;55(647):692-4. doi: 10.1136/pgmj.55.647.692. Postgrad Med J. 1979. PMID: 392486 Free PMC article.
• [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].

  Yamaguchi H. Yamaguchi H. Rinsho Byori. 1997 Jul;Suppl 105:182-90. Rinsho Byori. 1997. PMID: 9379538 Review. Japanese. No abstract available.
• Nature and development of phenotypic resistance to amphotericin B in Candida albicans.

  Gale EF. Gale EF. Adv Microb Physiol. 1986;27:277-320. doi: 10.1016/s0065-2911(08)60307-0. Adv Microb Physiol. 1986. PMID: 3532717 Review. No abstract available.